Managing Director, Head of the US Enterprise Risk Solutions and Stress Testing Sales Teams
David is responsible for helping financial institutions worldwide with their enterprise risk management, liquidity, and stress testing solutions. Since joining Moody’s in 2002, David has been Managing Director in the product strategy group, responsible for a global portfolio of research, data, and analytic products across all fixed income asset classes, led end-of-day pricing business at Moody’s Evaluations Inc., and headed the global structured finance sales team at Moody’s Analytics.
David holds a BA in Economics and Political Science from Yale University and an MBA, with distinction, from the New York University Stern School of Business.
This article outlines recent approaches to managing credit risk when facing regulatory capital requirements. We explore how institutions should best allocate capital and make economically-optimized investment decisions under regulatory capital constraints, such as those imposed by Basel or CCAR-style rules.
In this article, we review the common themes reflected in recent regulatory guidelines released by the Federal Reserve and the BCBS.
December 2015 was a busy month for regulatory agencies and global standard setters. Throughout the year the industry has been waiting for additional guidance on high impact topics including capital planning and allowance methodologies, and in the final stretch of 2015 both the Federal Reserve and the Basel Committee on Banking Supervision (BCBS) complied. This paper will primarily focus on common themes in the two releases.
In an effort to better understand the stress testing challenges faced by US banks, David Little and his team have conducted a banking survey during a series of roundtables.
This article discusses the importance of managing and measuring liquidity risk, regulatory guidelines and implications, and how an effective enterprise-wide stress testing program requires and integrates liquidity risk.